- R&D
With its squishy synthetic platelets, the startup SelSym seeks to reduce risk from bleeding
Platelets are always in low supply with an additional problem with these sticky cell pieces being that platelets usually need to be utilized within...No Proof of Brain Injury in ‘Havana Syndrome’ Patients
A comprehensive series of sophisticated examinations conducted by researchers revealed the absence of brain injuries or degenerative conditions among U.S. diplomats and governmental staff...Semaglutide Shows Promise in Treating Liver Fat in HIV Patients
In a recent unveiling at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), a study illuminated the potential of semaglutide, a medication frequently...Prolonged Epigenetic Suppression in Mice Strengthens Argument for Therapeutic Applications
Recent mouse study findings suggest that epigenetic gene silencing could effectively hinder a target gene for a substantial duration, potentially nearing a...
- Clinical
MaaT Touts 18-Month Data as Proof of Microbiome Therapy Viability
Microbiome biotech MaaT Pharma says it will market its pooled fecal treatment medicine for acute graft-versus-host disease (aGvHD) in two years based on data...Zeposia medication from Bristol Myers Squibb falls short in a study for Crohn’s disease
As a therapy for two uncommon illnesses, ulcerative colitis (UC) and multiple sclerosis (MS), Bristol Myers Squibb's Zeposia (ozanimod) has garnered interest. However, the...Promising phase 3 results propel Bayer’s menopause drug towards approval
Bayer's recent announcement regarding its intention to seek regulatory approval for its menopause drug marks a development in the realm of women's health therapeutics....Pfizer’s Adcetris Shows Promise in Extending Survival for Lymphoma Patients
The pharmaceutical giant Pfizer revealed positive results from a late-stage study showcasing the efficacy of its drug, Adcetris, in prolonging survival among patients diagnosed...
- Manufacturing
Novo Nordisk invests $560 million to increase Chinese medicine production
Novo Nordisk, a prominent player in the pharmaceutical industry, is commemorating three decades of operations in China, coinciding with the potential approval of its...Rovi’s Expansion in Pharmaceutical Production with Moderna
The Laboratorios Farmacéuticos Rovi and Moderna partnership has recently achieved a milestone with the establishment of a new production facility aimed at...Bristol Myers Squibb Expands Irish Campus with $400M Investment in Drug Manufacturing
Bristol Myers Squibb (BMS) has disclosed a significant infusion of $400 million into its Cruiserath Campus located in Dublin 15, also recognized...Trial for Gritstone’s BARDA-funded COVID-19 vaccine delayed due to production issues
Gritstone Bio has secured a substantial sum of $433 million in federal funding earmarked for the testing of its cutting-edge COVID-19 vaccine....
- Commercial
Highridge Medical: ZimVie’s successful spinout of its spine division
The successful sale of ZimVie's spine division to investment firm H.I.G. Capital has triggered many noteworthy developments in the medical space that have resulted...Olympus Joins Hands With American Lung Association For Cancer Education
Olympus has joined forces with the American Lung Association (ALA) to raise awareness about the detection and staging of lung nodules, supporting educational materials...Johnson Matthey Sells Medical Metal Unit to Montagu in $700M Deal
Johnson Matthey, a British corporation specializing in metals and chemicals, is preparing to divest its global Medical Device Components (MDC) division, which encompasses manufacturing...
- Technology
Microscopic “super bots” repair neural wound model
In a recent development, scientists have brought science fiction to life by creating miniature biological robots, known as biobots, capable of healing...Amgen Expands Amazon Partnership to Seek Generative AI Solutions
In a concerted effort to enhance the discovery and manufacturing processes of pharmaceuticals, Amgen is broadening its longstanding alliance with the technology...Siemens Healthineers & Qure.ai partnership Aims to Enhance Tuberculosis Diagnosis Using AI
Siemens Healthineers, in collaboration with Qure.ai and the Global Fund to Combat AIDS, Tuberculosis, and Malaria, is spearheading an initiative to expedite...Philips Launches New Platform to Improve Health Monitoring
Over two years following the acquisition of the medical information aggregator Capsule Technologies, Philips is introducing an innovative integrated information platform. This...
- Regulatory
FDA puts Neumora’s schizophrenia medication on hold because of rabbit convulsions
The FDA has placed Neumora's schizophrenia medication on hold due to reports of convulsions in rabbits. Neumora Therapeutics' phase 1 study aimed at treating...Eisai and Biogen’s injectable Alzehimer drug faces setback from the FDA
First, due to the burden on its patients and healthcare infrastructure, and now with the Food and Drug Administration's (FDA) demand that they submit...Regeneron to conduct confirmatory trials for odronextamab for FDA approval
Mohsin Riaz - 0With Regeneron’s desire to move its blood cancer medicine odronextamab from fifth line to first in some instances as treatment, the Food and Drug...With FDA clearance, Akebia’s Vafseo finally has a chance to compete in the US chronic renal disease market
Despite a setback when the FDA denied its first effort at clearance for Vafseo, an oral therapy for chronic kidney disease (CKD) anemia, two...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
- R&D
With its squishy synthetic platelets, the startup SelSym seeks to reduce risk from bleeding
Platelets are always in low supply with an additional problem with these sticky cell pieces being that platelets usually need to be utilized within...No Proof of Brain Injury in ‘Havana Syndrome’ Patients
A comprehensive series of sophisticated examinations conducted by researchers revealed the absence of brain injuries or degenerative conditions among U.S. diplomats and governmental staff...Semaglutide Shows Promise in Treating Liver Fat in HIV Patients
In a recent unveiling at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), a study illuminated the potential of semaglutide, a medication frequently...Prolonged Epigenetic Suppression in Mice Strengthens Argument for Therapeutic Applications
Recent mouse study findings suggest that epigenetic gene silencing could effectively hinder a target gene for a substantial duration, potentially nearing a...
- Clinical
MaaT Touts 18-Month Data as Proof of Microbiome Therapy Viability
Microbiome biotech MaaT Pharma says it will market its pooled fecal treatment medicine for acute graft-versus-host disease (aGvHD) in two years based on data...Zeposia medication from Bristol Myers Squibb falls short in a study for Crohn’s disease
As a therapy for two uncommon illnesses, ulcerative colitis (UC) and multiple sclerosis (MS), Bristol Myers Squibb's Zeposia (ozanimod) has garnered interest. However, the...Promising phase 3 results propel Bayer’s menopause drug towards approval
Bayer's recent announcement regarding its intention to seek regulatory approval for its menopause drug marks a development in the realm of women's health therapeutics....Pfizer’s Adcetris Shows Promise in Extending Survival for Lymphoma Patients
The pharmaceutical giant Pfizer revealed positive results from a late-stage study showcasing the efficacy of its drug, Adcetris, in prolonging survival among patients diagnosed...
- Manufacturing
Novo Nordisk invests $560 million to increase Chinese medicine production
Novo Nordisk, a prominent player in the pharmaceutical industry, is commemorating three decades of operations in China, coinciding with the potential approval of its...Rovi’s Expansion in Pharmaceutical Production with Moderna
The Laboratorios Farmacéuticos Rovi and Moderna partnership has recently achieved a milestone with the establishment of a new production facility aimed at...Bristol Myers Squibb Expands Irish Campus with $400M Investment in Drug Manufacturing
Bristol Myers Squibb (BMS) has disclosed a significant infusion of $400 million into its Cruiserath Campus located in Dublin 15, also recognized...Trial for Gritstone’s BARDA-funded COVID-19 vaccine delayed due to production issues
Gritstone Bio has secured a substantial sum of $433 million in federal funding earmarked for the testing of its cutting-edge COVID-19 vaccine....
- Commercial
Highridge Medical: ZimVie’s successful spinout of its spine division
The successful sale of ZimVie's spine division to investment firm H.I.G. Capital has triggered many noteworthy developments in the medical space that have resulted...Olympus Joins Hands With American Lung Association For Cancer Education
Olympus has joined forces with the American Lung Association (ALA) to raise awareness about the detection and staging of lung nodules, supporting educational materials...Johnson Matthey Sells Medical Metal Unit to Montagu in $700M Deal
Johnson Matthey, a British corporation specializing in metals and chemicals, is preparing to divest its global Medical Device Components (MDC) division, which encompasses manufacturing...
- Technology
Microscopic “super bots” repair neural wound model
In a recent development, scientists have brought science fiction to life by creating miniature biological robots, known as biobots, capable of healing...Amgen Expands Amazon Partnership to Seek Generative AI Solutions
In a concerted effort to enhance the discovery and manufacturing processes of pharmaceuticals, Amgen is broadening its longstanding alliance with the technology...Siemens Healthineers & Qure.ai partnership Aims to Enhance Tuberculosis Diagnosis Using AI
Siemens Healthineers, in collaboration with Qure.ai and the Global Fund to Combat AIDS, Tuberculosis, and Malaria, is spearheading an initiative to expedite...Philips Launches New Platform to Improve Health Monitoring
Over two years following the acquisition of the medical information aggregator Capsule Technologies, Philips is introducing an innovative integrated information platform. This...
- Regulatory
FDA puts Neumora’s schizophrenia medication on hold because of rabbit convulsions
The FDA has placed Neumora's schizophrenia medication on hold due to reports of convulsions in rabbits. Neumora Therapeutics' phase 1 study aimed at treating...Eisai and Biogen’s injectable Alzehimer drug faces setback from the FDA
First, due to the burden on its patients and healthcare infrastructure, and now with the Food and Drug Administration's (FDA) demand that they submit...Regeneron to conduct confirmatory trials for odronextamab for FDA approval
Mohsin Riaz - 0With Regeneron’s desire to move its blood cancer medicine odronextamab from fifth line to first in some instances as treatment, the Food and Drug...With FDA clearance, Akebia’s Vafseo finally has a chance to compete in the US chronic renal disease market
Despite a setback when the FDA denied its first effort at clearance for Vafseo, an oral therapy for chronic kidney disease (CKD) anemia, two...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
Editor Picks
FDA Lifts Partial Hold on Iovance’s Cancer Therapy Trial
Iovance Biotherapeutics has had a partial clinical hold imposed by the FDA....
Pfizer to cough up $345 million to resolve lawsuits over EpiPen price hikes.
Pfizer along with its two subsidiaries ̶ Maryland-based Meridian Medical Technologies and Tennessee-based King Pharmaceuticals
Kronos trims staff by 19% for phase 1/2 solid tumor drug
Kronos Bio, following promising outcomes in an initial evaluation of a phase...
Must Read
With its squishy synthetic platelets, the startup SelSym seeks to reduce risk from bleeding
Platelets are always in low supply with an additional problem with these sticky cell...
FDA puts Neumora’s schizophrenia medication on hold because of rabbit convulsions
The FDA has placed Neumora's schizophrenia medication on hold due to reports of convulsions...
MaaT Touts 18-Month Data as Proof of Microbiome Therapy Viability
Microbiome biotech MaaT Pharma says it will market its pooled fecal treatment medicine for...
About Us
Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.
Contact us: reachout(at)lifescivoice.com